Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06109779
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-10-26
Brief Title:
Rilvegostomig Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection ARTEMIDE-Biliary01
Sponsor:
Organization:
AstraZeneca